EC Healthcare Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Leslie Lu
Algemeen directeur
HK$4.8m
Totale compensatie
| Percentage CEO-salaris | 99.6% |
| Dienstverband CEO | less than a year |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 2.3yrs |
| Gemiddelde ambtstermijn bestuur | 8.8yrs |
Recente managementupdates
Recent updates
EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends
Nov 13
Little Excitement Around EC Healthcare's (HKG:2138) Revenues As Shares Take 31% Pounding
Sep 05EC Healthcare (HKG:2138) Might Be Having Difficulty Using Its Capital Effectively
Jul 26EC Healthcare (HKG:2138) Surges 25% Yet Its Low P/S Is No Reason For Excitement
May 13When Should You Buy EC Healthcare (HKG:2138)?
Apr 26Is EC Healthcare (HKG:2138) A Risky Investment?
Feb 07Slammed 26% EC Healthcare (HKG:2138) Screens Well Here But There Might Be A Catch
Dec 24EC Healthcare's (HKG:2138) Dividend Is Being Reduced To HK$0.005
Dec 08Here's What's Concerning About EC Healthcare's (HKG:2138) Returns On Capital
Dec 01At HK$3.13, Is EC Healthcare (HKG:2138) Worth Looking At Closely?
Sep 15EC Healthcare (HKG:2138) Is Paying Out A Dividend Of HK$0.042
Aug 24Is EC Healthcare (HKG:2138) Using Too Much Debt?
Aug 10EC Healthcare (HKG:2138) Has Announced A Dividend Of HK$0.042
Jul 14EC Healthcare (HKG:2138) Will Pay A Dividend Of HK$0.042
Jun 26Is There Now An Opportunity In EC Healthcare (HKG:2138)?
Jun 15Be Wary Of EC Healthcare (HKG:2138) And Its Returns On Capital
May 12Is EC Healthcare (HKG:2138) Potentially Undervalued?
Mar 08EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends
Feb 03EC Healthcare (HKG:2138) Is Paying Out Less In Dividends Than Last Year
Dec 20Is Now An Opportune Moment To Examine EC Healthcare (HKG:2138)?
Oct 25EC Healthcare (HKG:2138) Is Reinvesting At Lower Rates Of Return
Sep 20EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042
Sep 01EC Healthcare's (HKG:2138) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 28EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042
Jul 14EC Healthcare (HKG:2138) Is Reducing Its Dividend To HK$0.042
Jun 26When Should You Buy EC Healthcare (HKG:2138)?
May 26EC Healthcare (HKG:2138) Will Be Hoping To Turn Its Returns On Capital Around
Apr 18Is It Too Late To Consider Buying EC Healthcare (HKG:2138)?
Feb 24EC Healthcare (HKG:2138) Could Easily Take On More Debt
Feb 11Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Mar 31 2024 | HK$5m | HK$5m | -HK$19m |
| Dec 31 2023 | n/a | n/a | -HK$11m |
| Sep 30 2023 | n/a | n/a | -HK$4m |
| Jun 30 2023 | n/a | n/a | HK$33m |
| Mar 31 2023 | HK$21m | HK$4m | HK$70m |
| Dec 31 2022 | n/a | n/a | HK$93m |
| Sep 30 2022 | n/a | n/a | HK$117m |
| Jun 30 2022 | n/a | n/a | HK$157m |
| Mar 31 2022 | HK$13m | HK$2m | HK$198m |
Compensatie versus markt: De totale vergoeding ($USD 618.91K ) Leslie } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 232.96K ).
Compensatie versus inkomsten: De vergoeding van Leslie is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Leslie Lu (44 yo)
less than a year
Tenure
HK$4,818,000
Compensatie
Mr. Lyn Wade Lu, also known as Leslie, served as Co-Chief Executive Officer & Executive Director at EC Healthcare since August 23, 2021 until November 1, 2023. He serves as Chief Executive Officer at EC He...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder & Executive Chairman | 9yrs | HK$1.24m | 60.93% HK$ 512.8m | |
| Chief Executive Officer & Executive Director | less than a year | HK$4.82m | geen gegevens | |
| CFO & Executive Director | 5.3yrs | HK$3.77m | 0.057% HK$ 483.2k | |
| Chief Operating Officer | 2.3yrs | geen gegevens | geen gegevens | |
| Associate Director of Accounting | no data | geen gegevens | geen gegevens | |
| Chief Public Affairs Officer & Chief Dental Officer | 2.3yrs | geen gegevens | geen gegevens | |
| Sales Director | no data | geen gegevens | geen gegevens | |
| Chief Business Officer | 4.2yrs | geen gegevens | geen gegevens | |
| Chief Talent Officer | 2.3yrs | geen gegevens | geen gegevens | |
| Chief Proposition Officer of Healthcare | 1.8yrs | geen gegevens | geen gegevens | |
| Company Secretary | 7.2yrs | geen gegevens | geen gegevens |
2.3yrs
Gemiddelde duur
45yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van 2138 wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.3 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder & Executive Chairman | 9yrs | HK$1.24m | 60.93% HK$ 512.8m | |
| Chief Executive Officer & Executive Director | 3.3yrs | HK$4.82m | geen gegevens | |
| CFO & Executive Director | 4.8yrs | HK$3.77m | 0.057% HK$ 483.2k | |
| Independent Non-Executive Director | 8.8yrs | HK$240.00k | 0.025% HK$ 213.0k | |
| Independent Non-Executive Director | 8.8yrs | HK$220.00k | geen gegevens | |
| Non Executive Director | 9.2yrs | HK$126.00k | 0.24% HK$ 2.0m | |
| Independent Non-Executive Director | 2.2yrs | HK$120.00k | geen gegevens |
8.8yrs
Gemiddelde duur
44yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 2138 wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.8 jaar).